ORIC Pharmaceuticals, Inc. · NASDAQ:ORIC
EcoR1 Capital, LLC's stake in ORIC Pharmaceuticals, Inc. fell to 2.90% (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
EcoR1 Capital, LLC's stake in ORIC Pharmaceuticals, Inc. fell to 2.90%, 3,028,116 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 2.90%
- Shares
- 3,028,116
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| EcoR1 Capital, LLC | 2.90% | 3,028,116 |
| Oleg Nodelman | 2.90% | 3,028,116 |
| EcoR1 Capital Fund Qualified, L.P. | 2.80% | 2,885,435 |
Source
Download original · View original at SEC
Related
- ORIC Pharmaceuticals, Inc.
- EcoR1 Capital, LLC
- ORIC Pharmaceuticals, Inc. shareholders
- Schedule 13G · EcoR1 Capital, LLC · Aug 5, 2025
- Schedule 13G/A · Viking Global Investors LP · Nov 16, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Nov 16, 2026
- Form 4 · Piscitelli Dominic · Oct 21, 2026
- Form 4 · Heyman Richard A. · Oct 2, 2026
- Form 4 · Piscitelli Dominic · Sep 29, 2026